Aceto Corporation (ACET) Given Coverage Optimism Score of 0.12

News articles about Aceto Corporation (NASDAQ:ACET) have been trending somewhat positive on Sunday, Accern Sentiment reports. Accern rates the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aceto Corporation earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.8020017847472 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

A number of equities analysts have recently issued reports on ACET shares. Canaccord Genuity set a $15.00 price objective on shares of Aceto Corporation and gave the stock a “buy” rating in a research report on Monday, October 30th. Zacks Investment Research cut shares of Aceto Corporation from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 9th. Finally, ValuEngine raised shares of Aceto Corporation from a “hold” rating to a “buy” rating in a research report on Wednesday, September 13th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $15.00.

Shares of Aceto Corporation (NASDAQ ACET) traded down $0.05 during midday trading on Friday, reaching $10.08. 307,146 shares of the company traded hands, compared to its average volume of 455,698. Aceto Corporation has a twelve month low of $8.29 and a twelve month high of $22.46. The company has a market cap of $303.50, a PE ratio of 8.40, a price-to-earnings-growth ratio of 0.94 and a beta of 1.38. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.46 and a current ratio of 2.06.

Aceto Corporation (NASDAQ:ACET) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.28 by $0.02. Aceto Corporation had a net margin of 1.07% and a return on equity of 10.18%. The business had revenue of $185.26 million for the quarter, compared to analysts’ expectations of $190.58 million. During the same quarter last year, the firm earned $0.28 EPS. The firm’s revenue for the quarter was up 44.7% compared to the same quarter last year. equities analysts predict that Aceto Corporation will post 1.07 EPS for the current fiscal year.

In other Aceto Corporation news, Chairman Albert L. Eilender sold 9,530 shares of Aceto Corporation stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $10.47, for a total transaction of $99,779.10. Following the transaction, the chairman now owns 307,028 shares of the company’s stock, valued at approximately $3,214,583.16. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Walter J. Kaczmarek III sold 2,635 shares of Aceto Corporation stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $10.57, for a total transaction of $27,851.95. Following the transaction, the chief operating officer now directly owns 72,817 shares in the company, valued at approximately $769,675.69. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,283 shares of company stock worth $275,189. 4.10% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at

Aceto Corporation Company Profile

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.

Insider Buying and Selling by Quarter for Aceto Corporation (NASDAQ:ACET)

Receive News & Ratings for Aceto Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto Corporation and related companies with's FREE daily email newsletter.

Leave a Reply